Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population.

TitleNeuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population.
Publication TypeJournal Article
Year of Publication2022
AuthorsGodrich D, Martin ER, Schellenberg G, Pericak-Vance MA, Cuccaro M, Scott WK, Kukull W, Montine T, Beecham GW
JournalAlzheimers Dement
Volume18
Issue12
Pagination2403-2412
Date Published12/2022
ISSN1552-5279
KeywordsAlzheimer Disease, Brain, Cognitive Dysfunction, Humans, Lewy Bodies, Neurofibrillary Tangles, Plaque, Amyloid
Abstract

INTRODUCTION: Alzheimer disease (AD) and related dementias are characterized by damage caused by neuropathological lesions in the brain. These include AD lesions (plaques and tangles) and non-AD lesions such as vascular injury or Lewy bodies. We report here an assessment of lesion association to dementia in a large clinic-based population.

METHODS: We identified 5272 individuals with neuropathological data from the National Alzheimer's Coordinating Center. Individual lesions, as well as a neuropathological composite score (NPCS) were tested for association with dementia, and both functional and neurocognitive impairment using regression models.

RESULTS: Most individuals exhibited mixed pathologies, especially AD lesions in combination with non-AD lesions. All lesion types were associated with one or more clinical outcomes; most even while controlling for AD pathology. The NPCS was also associated with clinical outcomes.

DISCUSSION: These data suggest mixed-type pathologies are extremely common in a clinic-based population and may contribute to dementia and cognitive impairment.

DOI10.1002/alz.12516
Alternate JournalAlzheimers Dement
PubMed ID35142102
PubMed Central IDPMC9360193
Grant ListP30 AG010133 / AG / NIA NIH HHS / United States
U24 AG072122 / AG / NIA NIH HHS / United States
U01 AG032984 / AG / NIA NIH HHS / United States
P30 AG062421 / AG / NIA NIH HHS / United States
P30 AG062422 / AG / NIA NIH HHS / United States
P30 AG062429-01 / AG / NIA NIH HHS / United States
P30 AG062422-01 / AG / NIA NIH HHS / United States
P30 AG062428-01 / AG / NIA NIH HHS / United States
P30 AG072976 / AG / NIA NIH HHS / United States
R01 AG062695 / AG / NIA NIH HHS / United States
P30 AG062421-01 / AG / NIA NIH HHS / United States
P30 AG013854 / AG / NIA NIH HHS / United States
P30 AG053760 / AG / NIA NIH HHS / United States
P30 AG072975 / AG / NIA NIH HHS / United States
U01 AG016976 / AG / NIA NIH HHS / United States
P30 AG062715-01 / AG / NIA NIH HHS / United States